neulasta.com

neulasta.com

Neulasta® (pegfilgrastim) | G-CSF Injection Neulasta® (pegfilgrastim) | G-CSF Injection
Monthly Visitors 14K
Global Rank 757277
Estimated Price $2,448

Summary

Domain age of Neulasta.com is 14 years. Traffic is around 16K visitors during previous month, which corresponds to 757277 place in the global site ranking. During this month, traffic to site has decreased by 13% compared to previous month, and equals to 14K visitors. Estimated potential revenue of this site may be up to $68 per month. We did not find any sites that have the same ID at Analytics and/or Adsence. According to our information, it is safe to visit Neulasta.com.

Monthly Visitors

Now loading ...
Dec'16 (est) 14K
Nov'16 (est) 16K
Oct'16 (est) 14K
Sep'16 (est) 12K
Aug'16 (est) 14K
Jul'16 (est) 14K
Jun'16 (est) 16K
May'16 (est) 16K
Apr'16 (est) 16K
Mar'16 (est) 16K
Feb'16 (est) 16K
Jan'16 (est) 14K
Dec'15 (est) 32K

SiteGur Score

Now loading ...
Dec'16 -2428
Nov'16 -277
Oct'16 2309
Sep'16 -442
Aug'16 884
Jul'16 -1795
Jun'16 1099
May'16 480
Apr'16 -208
Mar'16 -1001
Feb'16 2049
Jan'16 -7990
Dec'15 -1104

Similar Sites

  • cialis.com cialis.com ED and BPH Treatment | CIALIS (tadalafil) tablets ED and BPH Treatment | CIALIS (tadalafil) tablets
  • januvia.com januvia.com Type 2 Diabetes Medication | JANUVIA ® (sitagliptin) tablets Type 2 Diabetes Medication | JANUVIA ® (sitagliptin) tablets
  • spiriva.com spiriva.com Spiriva Spiriva
  • vivitrol.com vivitrol.com VIVITROL ® | Official Site VIVITROL ® | Official Site
  • truvada.com truvada.com TRUVADA® (emtricitabine and tenofovir disoproxil fumarate) TRUVADA® (emtricitabine and tenofovir disoproxil fumarate)
  • qsymia.com qsymia.com Qsymia ® (Phentermine and Topiramate extended-release) Capsules CIV | Official Site - prescription weight-loss medicine Qsymia ® (Phentermine and Topiramate extended-release) Capsules CIV | Official Site - prescription weight-loss medicine
  • forteo.com forteo.com Osteoporosis Treatment Medication FORTEO [teriparatide (rDNA origin) injection] Osteoporosis Treatment Medication FORTEO [teriparatide (rDNA origin) injection]
  • revlimid.com revlimid.com REVLIMID® (lenalidomide) Treatment for Multiple Myeloma | Mantle Cell Lymphoma | Deletion 5q Myelodysplastic Syndromes REVLIMID® (lenalidomide) Treatment for Multiple Myeloma | Mantle Cell Lymphoma | Deletion 5q Myelodysplastic Syndromes
  • jardiance.com jardiance.com Type 2 diabetes medication & treatment | Jardiance ® (empagliflozin) tablets Type 2 diabetes medication & treatment | Jardiance ® (empagliflozin) tablets
  • xyrem.com xyrem.com XYREM® and Narcolepsy Treatment Information XYREM® and Narcolepsy Treatment Information
  • show more...

Estimated Cost and Revenue

Neulasta.com value: $2,448

Daily Ads revenue: $2

Monthly Ads revenue: $68

Yearily Ads revenue: $816

Now loading ...

Other information

Domain.com creation: 10 January 2002 expired: 10 January 2016
Archive.org information first time archived: 22 May 2002 last time archived: 11 July 2015 how many times: 509

Whois report

Whois Server Version 2.0
Domain names in the .com and .net domains can now be registered
with many different competing registrars. Go to http://www.internic.net
for detailed information.
   Domain Name: NEULASTA.COM
   Registrar: MARKMONITOR INC.
   Sponsoring Registrar IANA ID: 292
   Whois Server: whois.markmonitor.com
   Referral URL: http://www.markmonitor.com
   Name Server: NS1.AMGENWEBNS.NET
   Name Server: NS2.AMGENWEBNS.NET
   Status: clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited
   Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
   Status: clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited
   Updated Date: 10-dec-2014
   Creation Date: 11-jan-2002
   Expiration Date: 11-jan-2016
>>> Last update of whois database: Mon, 14 Sep 2015 22:40:01 GMT <<<
NOTICE: The expiration date displayed in this record is the date the 
registrar's sponsorship of the domain name registration in the registry is 
currently set to expire. This date does not necessarily reflect the expiration 
date of the domain name registrant's agreement with the sponsoring 
registrar.  Users may consult the sponsoring registrar's Whois database to 
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois 
database through the use of electronic processes that are high-volume and 
automated except as reasonably necessary to register domain names or 
modify existing registrations; the Data in VeriSign Global Registry 
Services' ("VeriSign") Whois database is provided by VeriSign for 
information purposes only, and to assist persons in obtaining information 
about or related to a domain name registration record. VeriSign does not 
guarantee its accuracy. By submitting a Whois query, you agree to abide 
by the following terms of use: You agree that you may use this Data only 
for lawful purposes and that under no circumstances will you use this Data 
to: (1) allow, enable, or otherwise support the transmission of mass 
unsolicited, commercial advertising or solicitations via e-mail, telephone, 
or facsimile; or (2) enable high volume, automated, electronic processes 
that apply to VeriSign (or its computer systems). The compilation, 
repackaging, dissemination or other use of this Data is expressly 
prohibited without the prior written consent of VeriSign. You agree not to 
use electronic processes that are automated and high-volume to access or 
query the Whois database except as reasonably necessary to register 
domain names or modify existing registrations. VeriSign reserves the right 
to restrict your access to the Whois database in its sole discretion to ensure 
operational stability.  VeriSign may restrict or terminate your access to the 
Whois database for failure to abide by these terms of use. VeriSign 
reserves the right to modify these terms at any time. 
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
For more information on Whois status codes, please visit 
https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en.